MedPath

Time Trend Analysis of PE Diagnosis With SPECT V/Q: a Single Institution Observational Study

Completed
Conditions
Pulmonary Embolism
Registration Number
NCT03657992
Lead Sponsor
University Hospital, Brest
Brief Summary

Following the implementation of SPECT V/Q imaging for PE diagnosis, the investigators previously conducted an observational study over the period 2011-2013 that showed the safety of a diagnostic management based on SPECT V/Q to rule out PE. However, PE prevalence was high (28%), which may seem a bit high as compared with other recent studies. The hypothesis was that the use of SPECT V/Q may be responsible for an overdiagnosis of PE, especially at the implementation phase of the test. The aim of this study was to perform a time trend analysis of the evolution over the years of PE diagnosis with SPECT V/Q.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • Patients who underwent a SPECT V/Q scan performed for a suspected acute PE in the Nuclear Medicine Department of Brest University Hospital from April 2011 to December 2016
Exclusion Criteria
  • Patient under legal or judicial protection
  • Patient opposed to the use of his medical data for research.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnostic conclusion of all SPECT V/Q scans performed for a suspected acute PEApril 2011 to December 2016

positive, negative, or non-conclusive

Secondary Outcome Measures
NameTimeMethod
Risk of thromboembolic events (i.e. objectively confirmed pulmonary embolism or proximal deep vein thrombosis) during the 3-month follow-up period in patients left untreated based on a negative SPECT V/Q.up to 3 Months following the date of the SPECT V/Q scan

Trial Locations

Locations (1)

CHRU de Brest

🇫🇷

Brest, France

© Copyright 2025. All Rights Reserved by MedPath